What Is Alzheimer’s Disease?...

What Is Alzheimer’s Disease? Causes & Ayurvedic Treatment in Hyderabad | Dr. madhuri #AlzheimersDisease...

𝗙𝗜𝗥𝗦𝗧 𝗔𝗟𝗭𝗛𝗘𝗜𝗠𝗘𝗥’𝗦 𝗕𝗟𝗢𝗢𝗗 𝗧𝗘𝗦𝗧:...

Discover how the first FDA-cleared blood test for Alzheimer’s disease, developed by Fujirebio,...
HomeAlzheimerThe Cheryl Hauser...

The Cheryl Hauser Effect: Alzheimer’s, Autonomy and End of Life Choices


Listen and Subscribe to Alzheimer’s Speaks on Apple Podcast above

Lori La Bey talks with Wendy Longacre Brown, a certified end-of-life doula who is one of the founding members of the Minnesota Death Collaborative. She has supported clients in Minnesota and Wisconsin, worked alongside her mother through VSED, and brings decades of experience as a video and film producer in corporate and advertising settings.  

Sarah Longacre is Wendy’s sister and is a certified Birth Doula, entrepreneur, and community connector. She founded Blooma, a pioneering pre- and postnatal yoga and education studio, and has been recognized with multiple awards for her leadership in childbirth education. 

Subscribe, Watch, or Listen to Alzheimer’s Speaks on YouTube above.

LEARN:

  1. How do families typically make decisions about end of life, and what does that look like?
  2. When should palliative and hospice services be considered?
  3. What is a Death Doula or End-of-Life Doula
  4. What is VSED, and how does it work?
  5. Is VSED combined with hospice or Death Doulas?
  6. How do people educate themselves about VSED to be able to evaluate if the concept is right for them?
  7. How can family, friends, and professionals help provide dignity to the person they are caring for at the end of life?

DONATE TO THE FILM HERE

Listen or Subscribe to Alzheimer’s Speaks Podcast on Spotify

Contact The Cheryl Hauser Effect

Wendy Longacre Brown


Contact Lori La Bey Today

FeedSpot Honors Us Again For Being One Of The Best 20 Alzheimer’s Podcasts for 2025.

We are Thankful once again for being honored as a Top 10 Podcast! Thank you, Million Podcasts.

We are so proud to be recognized by Feedspot as a Top Blog & Website.

Finally, Answers To Help Educate Families Dealing With Dementia. Renowned Author Dr. Peter Rabins Shares Critical Answers to People's Questions About Alzheimer’s And Dementia

PLAN AHEAD! Maude’s Awards gives three annual $25,000 awards to organizations and up to five $5,000 awards to individuals. Applications are are currently closed

And How They Are Busting Stigmas By Highlighting Possibilities

Learn About The Programs Alzheimer’s Speaks Offers

Talk To Lori La Bey About Your Next Speaking Event for Staff or Families. She Offers A Variety Of Keynotes, Breakout Sessions, Trainings, and Fundraising Asks

Check Out Alzheimer’s Speaks FREE Educational Resources

Dementia Is not always easy, but there  is joy in the journey. Hear from a wife who shares her heartfelt stories & thoughts about caring for her husband living with dementia. Hear the ups, the downs & coping techniques

Dementia Chats Brings You Adapting to Brain Change on Alzheimer’s Speaks

There’s Still More To Learn About Alzheimer’s Speaks!

Lori La Bey and Alzheimer’s Speaks Can Help Your Organization With Staff Training, Family Support, Perspective Clients, and Support Gatherings.

Continue reading

What Is Alzheimer’s Disease? Causes & Ayurvedic Treatment in Hyderabad | Dr. madhuri

What Is Alzheimer’s Disease? Causes & Ayurvedic Treatment in Hyderabad | Dr. madhuri #AlzheimersDisease #MemoryLoss #AyurvedaForBrain #DrMadhuri #VardhanAyurveda #TeluguHealthTips #Forgetfulness #AyurvedicTreatment #BrainHealth #NaturalHealing Do you or your loved ones often forget names, places, or daily tasks? It could be more than...

Genetic Mismatch Triples Severe Immune Risk

Cord blood transplants are known to tolerate genetic mismatches better than other donor sources. But one specific HLA pairing may sharply raise the risk of severe...

𝗙𝗜𝗥𝗦𝗧 𝗔𝗟𝗭𝗛𝗘𝗜𝗠𝗘𝗥’𝗦 𝗕𝗟𝗢𝗢𝗗 𝗧𝗘𝗦𝗧: 𝗚𝗔𝗠𝗘-𝗖𝗛𝗔𝗡𝗚𝗘𝗥 𝗜𝗡 𝗘𝗔𝗥𝗟𝗬 𝗗𝗜𝗔𝗚𝗡𝗢𝗦𝗜𝗦

Discover how the first FDA-cleared blood test for Alzheimer’s disease, developed by Fujirebio, is transforming early detection and diagnosis. This breakthrough not only simplifies screening but also brings huge economic and clinical value—especially amid shrinking federal funding for Alzheimer’s...